NCT05024214 2025-05-29Phase Ib/II Trial of Envafolimab Plus Lenvatinib for Subjects With Solid Tumors3D MedicinesPhase 1/2 Recruiting170 enrolled
NCT04910386 2024-08-14Multicenter Phase 2 Study of Envafolimab in Biliary Tract Cancers3D MedicinesPhase 2 Not yet recruiting126 enrolled